Lipe & Dalton’s Oracle ORCL Stock Holding History

Lipe & Dalton’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Hold	7,421	–	–	0.51%	45
2026 Q1	$1.09M	Hold	7,421	–	–	0.57%	43
2025 Q4	$1.45M	Buy	7,421 +30	+0.4%	+$7.14K	0.71%	40
2025 Q3	$2.08M	Sell	7,391 -150	-2%	-$38.2K	1.03%	33
2025 Q2	$1.65M	Hold	7,541	–	–	0.89%	41
2025 Q1	$1.05M	Hold	7,541	–	–	0.59%	47
2024 Q4	$1.26M	Hold	7,541	–	–	0.67%	42
2024 Q3	$1.28M	Sell	7,541 -900	-11%	-$130K	0.65%	48
2024 Q2	$1.19M	Sell	8,441 -640	-7%	-$79.5K	0.64%	45
2024 Q1	$1.14M	Hold	9,081	–	–	0.59%	46
2023 Q4	$957K	Hold	9,081	–	–	0.52%	50
2023 Q3	$962K	Hold	9,081	–	–	0.58%	50
2023 Q2	$1.08M	Sell	9,081 -504	-5%	-$52.1K	0.62%	49
2023 Q1	$891K	Hold	9,585	–	–	0.51%	52
2022 Q4	$783K	Hold	9,585	–	–	0.45%	54
2022 Q3	$585K	Hold	9,585	–	–	0.37%	57
2022 Q2	$670K	Hold	9,585	–	–	0.39%	56
2022 Q1	$793K	Hold	9,585	–	–	0.39%	55
2021 Q4	$836K	Sell	9,585 -340	-3%	-$31.9K	0.4%	56
2021 Q3	$865K	Hold	9,925	–	–	0.44%	53
2021 Q2	$773K	Sell	9,925 -900	-8%	-$70.5K	0.4%	55
2021 Q1	$760K	Hold	10,825	–	–	0.42%	53
2020 Q4	$700K	Buy	10,825 +70	+0.7%	+$4.17K	0.43%	51
2020 Q3	$642K	Hold	10,755	–	–	0.45%	51
2020 Q2	$594K	Sell	10,755 -500	-4%	-$26.5K	0.43%	53
2020 Q1	$544K	Hold	11,255	–	–	0.46%	49
2019 Q4	$596K	Hold	11,255	–	–	0.4%	52
2019 Q3	$619K	Sell	11,255 -500	-4%	-$27.6K	0.45%	50
2019 Q2	$670K	Hold	11,755	–	–	0.48%	46
2019 Q1	$631K	Hold	11,755	–	–	0.46%	45
2018 Q4	$531K	Hold	11,755	–	–	0.43%	46
2018 Q3	$606K	Sell	11,755 -60	-0.5%	-$2.91K	0.41%	46
2018 Q2	$521K	Hold	11,815	–	–	0.38%	44
2018 Q1	$541K	Sell	11,815 -475	-4%	-$23.6K	0.39%	45
2017 Q4	$581K	Sell	12,290 -200	-2%	-$9.81K	0.4%	41
2017 Q3	$604K	Hold	12,490	–	–	0.42%	41
2017 Q2	$626K	Hold	12,490	–	–	0.41%	46
2017 Q1	$557K	Sell	12,490 -250	-2%	-$10.4K	0.4%	44
2016 Q4	$490K	Hold	12,740	–	–	0.35%	46
2016 Q3	$500K	Sell	12,740 -170	-1%	-$6.93K	0.33%	51
2016 Q2	$528K	Sell	12,910 -200	-2%	-$7.99K	0.36%	50
2016 Q1	$536K	Hold	13,110	–	–	0.42%	42
2015 Q4	$479K	Sell	13,110 -2,400	-15%	-$91.7K	0.39%	41
2015 Q3	$560K	Sell	15,510 -437	-3%	-$16.8K	0.46%	41
2015 Q2	$643K	Sell	15,947 -810	-5%	-$35.1K	0.46%	41
2015 Q1	$723K	Sell	16,757 -215	-1%	-$9.32K	0.5%	38
2014 Q4	$763K	Hold	16,972	–	–	0.51%	37
2014 Q3	$650K	Hold	16,972	–	–	0.43%	39
2014 Q2	$688K	Sell	16,972 -600	-3%	-$24.7K	0.43%	38
2014 Q1	$718K	Sell	17,572 -2,400	-12%	-$91.4K	0.48%	36
2013 Q4	$764K	Sell	19,972 -160	-0.8%	-$5.5K	0.52%	36
2013 Q3	$668K	Sell	20,132 -1,000	-5%	-$32.4K	0.49%	34
2013 Q2	$649K	Buy	+21,132	New	+$701K	0.54%	33

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lipe & Dalton's ORCL Position: Q2 2026 in Review

Lipe & Dalton held its Oracle (ORCL) position steady in Q2 2026 at 7,421 shares worth $1.09M. The position accounts for 0.51% of the portfolio, ranked #45.

Lipe & Dalton first reported a position in ORCL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.08M in Q3 2025. 3,507 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Lipe & Dalton held 7,421 shares of Oracle worth $1.09M as of Q2 2026.
Lipe & Dalton left its Oracle share count unchanged in Q2 2026.
Oracle made up 0.51% of Lipe & Dalton's portfolio in Q2 2026, its #45 holding.
Lipe & Dalton first reported a position in Oracle in Q2 2013 and has held it in 53 quarters since.
Lipe & Dalton's Oracle position peaked at $2.08M in Q3 2025.
3,507 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.